Aquilo Capital Management, LLC, 10% Owner at Spero Therapeutics, Inc. (SPRO), bought 185,374 shares at $17.87 ($3.4M) on 2021-08-30, disclosed to the SEC on 2021-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.87 | 44,042 | $787K | 23.0% |
| 2 | $17.87 | 44,042 | $787K | 23.0% |
| 3 | $18.93 | 48,645 | $921K | 27.0% |
| 4 | $18.93 | 48,645 | $921K | 27.0% |
| Total | $18.43 avg | 185,374 | $3.4M | 100% |
| Filing → |
| SPRO | BUY | 2022-02-23 | $274K | — | Filing → |
| SPRO | BUY | 2022-02-01 | $1.4M | — | Filing → |
| SPRO | BUY | 2022-01-20 | $1.2M | — | Filing → |